Indivior PLC (INDV.L)
INDV.L Stock Price Chart
Explore Indivior PLC interactive price chart. Choose custom timeframes to analyze INDV.L price movements and trends.
INDV.L Company Profile
Discover essential business fundamentals and corporate details for Indivior PLC (INDV.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
22 Dec 2014
Employees
1.03K
Website
https://www.indivior.comCEO
Joseph J. Ciaffoni
Description
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
INDV.L Financial Timeline
Browse a chronological timeline of Indivior PLC corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 18 Feb 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 31 Jul 2025
EPS came in at £0.11 falling short of the estimated £0.26 by -58.92%, while revenue for the quarter reached £221.59M , missing expectations by -9.37%.
Earnings released on 24 Apr 2025
EPS came in at £0.29 surpassing the estimated £0.24 by +22.63%, while revenue for the quarter reached £206.03M , missing expectations by -14.97%.
Earnings released on 20 Feb 2025
EPS came in at £0.35 surpassing the estimated £0.23 by +51.31%, while revenue for the quarter reached £238.93M , missing expectations by -0.50%.
Earnings released on 24 Oct 2024
EPS came in at £0.02 falling short of the estimated £0.26 by -91.32%, while revenue for the quarter reached £234.22M , missing expectations by -10.06%.
Earnings released on 25 Jul 2024
EPS came in at -£0.63 falling short of the estimated £0.32 by -296.51%, while revenue for the quarter reached £236.21M , beating expectations by +10.78%.
Earnings released on 25 Apr 2024
EPS came in at £0.27 falling short of the estimated £0.33 by -17.91%, while revenue for the quarter reached £226.25M , beating expectations by +6.11%.
Earnings released on 22 Feb 2024
EPS came in at £0.30 surpassing the estimated £0.24 by +27.70%, while revenue for the quarter reached £231.87M , beating expectations by +8.75%.
Earnings released on 9 Nov 2023
EPS came in at £0.34 surpassing the estimated £0.28 by +21.95%, while revenue for the quarter reached £222.76M , beating expectations by +4.52%.
Earnings released on 27 Jul 2023
EPS came in at £0.39 surpassing the estimated £0.22 by +77.27%, while revenue for the quarter reached £217.89M , beating expectations by +4.26%.
Earnings released on 27 Apr 2023
EPS came in at £0.25 , while revenue for the quarter reached £204.63M , missing expectations by -16.62%.
Earnings released on 16 Feb 2023
EPS came in at -£1.04 , while revenue for the quarter reached £196.46M , missing expectations by -75.42%.
Earnings released on 27 Oct 2022
EPS came in at £1.31 , while revenue for the quarter reached £209.70M , beating expectations by +7.85%.
Stock split effective on 10 Oct 2022
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Jul 2022
EPS came in at £0.27 , while revenue for the quarter reached £182.03M , beating expectations by +1.17%.
Earnings released on 28 Apr 2022
EPS came in at £0.21 , while revenue for the quarter reached £157.72M .
Earnings released on 16 Feb 2022
EPS came in at £0.17 , while revenue for the quarter reached £164.56M , beating expectations by +17.08%.
Earnings released on 28 Oct 2021
EPS came in at £0.67 , while revenue for the quarter reached £138.41M .
Earnings released on 29 Jul 2021
EPS came in at £0.29 , while revenue for the quarter reached £145.51M .
Earnings released on 29 Apr 2021
EPS came in at £0.37 , while revenue for the quarter reached £130.24M .
Earnings released on 18 Feb 2021
EPS came in at £0.15 , while revenue for the quarter reached £135.88M .
Earnings released on 29 Oct 2020
EPS came in at £0.10 , while revenue for the quarter reached £123.16M .
INDV.L Stock Performance
Access detailed INDV.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.